Transitional Committee
  
    HOME     ABOUT US     TIMETABLE     MEETINGS     PUBLICATIONS     CONTACT     BLOG     COMMENTS     PODCASTS    
About The Transitional Committee
The Chairman
 
The Chairman's role is to oversee the process of TransCom, chairing all the meetings in public and being present at the road shows. The Chair has responsibility for delivery of the Prospectus in December 2008.
 
Nigel Clarke
 
Nigel studied at Durham University, reading Psychology.
 
From 1985 - 2003, Nigel was a partner of GJW, then Europe's leading government relations firm. He served as finance director, led the healthcare practice, and was responsible for the creation of the company's Eastern European businesses between 1990-94.
 
In 2003, he set up Learned Lion Partners to develop projects in business areas with strong public policy influence. He is now a director of ATS Ltd, a company developing innovative public transport systems; is chairman of Newscounter; and is a founder and chief executive of Vidapulse Ltd, a medical research business.
 
Nigel has served on the General Osteopathic Council, the statutory regulatory body for the profession, since its inception in 1996. He was elected chairman in 2001. He also serves on the Council for Healthcare Regulatory Excellence, and as a Trustee of the Prince's Foundation for Integrated Health.
 
Earlier this year Nigel was involved in the first stage of the change in the pharmacy profession process; chairing the independent inquiry into a future professional body for pharmacy, commissioned by the RPSGB.
 


The Public Policy Adviser to TransCom
 
Professor David Taylor
 
David Taylor is Professor of Pharmaceutical and Public Health Policy at The School of Pharmacy, University of London and Chair of Camden and Islington (NHS) Mental Health and Social Care Trust. In this latter role he is responsible for the governance of an organisation spending about £130 million annually.
 
David's previous posts include Associate Director of Health Studies at the Audit Commission for England and Wales, a King's Fund Fellowship, and Director of Public and Economic Affairs at the Association of the British Pharmaceutical Industry. He also served on the Board of GJW Government Relations as Director of Health Affairs and as Deputy Director of the Office of Health Economics. There he worked on issues such as poor world health and the development of early models of devolved budget holding in the NHS. During the 1980s and early 1990s he was chair of Lambeth, Southwark and Lewisham Family Practitioner Committee/Family Health Services Authority.
 
He has published extensively on issues relating to health and health care. For example, at the Audit Commission he researched and wrote the national study Dear to our Hearts? and the national audit guide which accompanied it. He has competencies in health economics, health care quality management and health policy analysis. Current work includes studies on (global) public health policy formation; primary and pharmaceutical care policy in the UK; mental health care; service user support and information provision in the context of medicine taking and health improvement; and the future development of the European pharmaceutical market and health care in the EU.
 


The Project Co-ordinator
 
Grace Smallwood